18th Annual World Congress Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC) is organized by The Metabolic Institute of America (TMIOA). The onsite conference will be held from Dec 03 - 05, 2020 at Hilton Los Angeles/Universal City, Los Angeles, California, United States of America. Who can attend? This educational conference is intended for cardiologists, endocrinologists, gastroenterologists, oncologists, internists, diabetologists, OBGYNs, pediatricians, dietitians, nurse practitioners, pharmacists, and any other health care professionals who are interested in improving patients outcome, focusing on insulin resistance, diabetes, obesity, cardiovascular disease, related Kidney and fatty liver morbidity, and potential prevention and management impact on health and society. Program Description​: The World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC), now in its 18th year, is a unique and exciting multidisciplinary CME program. The Congress is the premiere global meeting dedicated to diabetes, obesity, lipids, cardiovascular disease (CVD), and energy balance, linking basic research to clinical practice in pursuit of our theme: Exploring New Frontiers in Metabolism — Tomorrow’s Clinical Science Today. For nearly two decades, WCIRDC has brought researchers, physicians- clinicians and other healthcare professionals together for a distinctive international program that bridges the latest developments from bench-to-bedside. “I heard it first at the Congress” is a frequent remark from the audience over the years, many of whom attend year after year. Researchers present their latest data and findings on everything from biomarkers to new physiological insights to new ideas for therapies. WCIRDC offers attendees a unique experience to interact in an intimate setting with the distinguished global faculty for a collaborative experience that explores the newest understanding of metabolic diseases and the development of future therapeutic modalities. Since Dr. Gerald Reaven’s pioneering work crystallized the relationship between insulin resistance (IR), diabetes, and CVD, the Congress’ focus has expanded to cover fat cells, lipids, the kidney, fatty liver, the brain, bone and energy metabolism, inflammation, aging, diet, cancer and more. The Congress addresses dyslipidemia, atherosclerosis, hypertension, and hypercoagulation as well as new pharmaceutical interventions such as incretins, SGLT2i’s, PCSK9i’s and EPA omega 3 to name a few. The goal is to understand the state-of-the-art pathophysiology new medical interventions and to develop appropriate comprehensive clinical management strategies. For primary care clinicians, Congress will feature a series of workshops and “meet the expert” panels addressing the clinical prevention and management of kidney disease, diabetes, obesity, lipids, the high risk CVD, CHF patient and more. To make basic and clinical research topics relevant to clinical medicine, following the presentations, including basic research, there will be commentaries on clinical implications to practice by recognized global experts. The Congress’ intimate setting promotes personal contacts between participants and the distinguished global faculty wherein everyone learns from the free flow of questions, personal observations and face to face informal discussions. The Congress attracts state-of-the-art abstracts by young, upcoming and recognized leaders from around the globe. These abstracts will be published in Metabolism: Clinical and Experimental, a peer-reviewed journal published twelve times a year with over 40,000 unique monthly viewers worldwide that is in the top 10% of endocrinology, diabetes, and metabolism journals (https://www.metabolismjournal.com/). Further, articles about the meeting are published in several medical journals and online medical news sources such as Diabetes Care, Metabolism, The Journal of Diabetes, Endocrine Practice, Diabetes and Vascular Disease Research, Endocrinology Today, Cardiology Today, Endocrine Web, Clinical Endocrinology News, Diabetes in Control, among others. Program Objectives: The program is intended to assess both the clinical and basic science aspects of diabetes, obesity, HTN, dyslipidemia, CHF, CVD, CKD and related cardiometabolic conditions by focusing on insulin resistance, hyperinsulinemia, fat Inflammation and energy metabolism. The goal is to understand the pathophysiology of each condition and develop appropriate comprehensive clinical management plans. At the conclusion of this session, an attendee will be able to,  • Explain the relationship between diabetes, obesity, and congestive heart failure • Explain the impact of lipotoxicity and the pathophysiology of CVD • Examine the role of obesity in the improvement of cardiometabolic conditions • Describe the purposes of diabetes in the addition of micro & macrovascular conditions: kidney disease, retinopathy, neuropathy, CVD and strokes • Present complete management of diabetes, through addressing obesity, hypertension, dyslipidemia and hyperglycemia • Address the role of incretins in the management of diabetes, obesity, and related complications • Appraise the confirmation supporting the use of SGLT2 inhibitors and GLP1ra's to reduce cardiovascular morbidity & mortality in patients with T2D and established CVD • Estimate the role of SGLT2i & GLP1ra for primary prevention of cardiovascular morbidity & mortality in patients with T2D • Note the role of PCSK9 inhibitors in preventing CV morbidity in people with established ASCVD • Know the relationship between fatty liver disease and diabetes along with CVD • Explain the pathogenesis of liver and muscle insulin resistance, the role of adipose tissue and of the mitochondria in hyperglycemia and ASCVD • Assess the influence on the clinical practice of recent CVD, CHF & CKD outcome trials • Evaluate the impact on the clinical practice of lipid CV outcome trials, including IMPROVE-IT, FOURIER, REDUCE-IT, ODYSSEY-Outcomes • Implement best practices for the prevention and management of CHF • Surmise the Cardiorenal Syndrome • Review the position of Coagulation and new anti-coagulation agents in the prevention of CVD and CVA • Discover about diminishing morbidity and mortality by being able to balance the correct medications to the appropriate patients

End Well Symposium 2020 is organized by End Well and will be held on Dec 08, 2020 at Skirball Cultural Center, Los Angeles, California, United States of America. Who is this for? End Well is a dynamic gathering of individuals committed to generating human-centered, interdisciplinary innovation for the end of life experience. • Entrepreneurs • Designers • Technologists • Funders • Health Care Providers • CaregiversPatients • Activists • Journalists • Policy Makers • Spiritual Leaders • Artists Course Description: End Well Symposium 2020 - Creating a future where ending well becomes a measure of living well. End Well is a dynamic gathering of individuals committed to generating human-centered, interdisciplinary innovation for the end of life experience. Additional details will be posted as soon as information is available.

PRESENT Treasure Hunt Conference is organized by PRESENT e-Learning Systems and will be held from Feb 20 - 21, 2021 at Hotel Indigo Los Angeles Downtown, Los Angeles, California, United States of America. Description: Previously, One of the largest county podiatry meetings in the country took place on February 8-9, 2020 in Los Angeles. The newest conference offered by PRESENT was supported by overflowing crowds in the lecture hall, workshops, and exhibit hall. Podiatry reality star Ebonie Vincent, DPM did live video reporting from the Conference which were broadcast on the PRESENT Facebook and LinkedIn channels. Additional details will be posted as soon as information is available.

The Evolution of Addiction Treatment 2021 is organized by C4 Recovery Foundation and will be held from Mar 02 - 05, 2021 at Sheraton Gateway Los Angeles Hotel, Los Angeles, California, United States of America. Description: Welcome to EVOLUTION — one of the addiction treatment industry’s top conferences for professionals to learn more about new ideas, innovative therapies and forward-thinking processes. Held annually in Los Angeles, EVOLUTION brings together experts in the field and professionals who are eager to stay on the cutting edge of addiction and behavioral health treatment. Additional details will be posted as soon as information is available.

8th Annual Pacific Retina Club (PRC) is organized by Medical Conference Planners International (MCPI) and will be held from Oct 08 - 09, 2021 at Los Angeles, California, United States of America. Additional details will be posted as soon as information is available.

CaliforniaAmerican Society of Human Genetics (ASHG) Annual Meeting 2022 is organized by American Society of Human Genetics and would be held during Oct 25 - 29, 2022 at Los Angeles, California, United States of America. The American Society of Human Genetics (ASHG) is the primary professional membership organization for human genetics specialists worldwide. The nearly 8,000 members include scientists, health care professionals, and others with an interest in human genetics. ASHG members work in a range of settings, including universities, hospitals, institutes, and medical and research laboratories.

North American Spine Society (NASS) 38th Annual Meeting is organized by North American Spine Society (NASS) and would be held during Oct 18 - 21, 2023 at Los Angeles, California, USA. The targeted audience for this medical meeting basically for Orthopedists.

Plastic Surgery The Meeting is organized by American Society of Plastic Surgeons (ASPS) and will be held during Oct 20 - 24, 2028 at Los Angeles, California, United States of America. Additional details will be posted as soon as they are available.

American Trauma Society (ATS) Trauma Registry Course (TRC) is organized by American Trauma Society (ATS) and will be held from Oct 22 - 23, 2020 at Cedars Sinai Medical Center - Harvey Morse, Los Angeles, California, United States of America. Description: Since 1987 the American Trauma Society has been the leader in Trauma Registry education around the country. The Trauma Registry Course (TRC) has been recognized by the American College of Surgeons in the Resources for Optimal Care of the Injured Patient since 1999 as an avenue for comprehensive trauma registry training. Two decades later, the American Trauma Society continues its legacy, offering industry leading training for Trauma Registry Professionals.   Beginning in November of 2018, the TRC underwent an extensive review by our lead faculty members and trauma registry experts. As a result, the TRC has been fully reimagined. The updated course is rooted in engagement and practical application strategies that registry professionals can transfer from the classroom back to the trauma center. All course materials are designed to augment experience, program maturity, and institutional needs. In this manner the TRC is designed and appropriate for trauma registrars / data managers of all levels of experience. This course provides the student with the most current national standard definitions, and methodologies essential to a comprehensive trauma registry. Course updates include:  • Focus on ICD-10 and GCS-40 • 2019 Updates to National Trauma Data Bank • ACS TQIP Best Practice Guidelines • Scenario Based Chart Abstraction • Emphasis on Coding and Scoring • Enhanced Performance Improvement Strategies • and so much more! The TRC is taught in a two day format that is broken down into interactive sessions which provide a comprehensive overview of trauma registry practices and functions.  Sessions include lectures, case studies, real world examples, group engagement, and take-home supplemental materials. Objectives: Upon completion of the Trauma Registry Course, the learner will be able to: • Identify the fundamental elements of a trauma registry, • Identify the fundamental elements of the National Trauma Data Standard dataset patient inclusion criteria, • Achieve familiarity with the National Trauma Data Standards, their definitions, field values, and required associated elements, • Achieve familiarity with anatomical and medical terms frequently used in trauma, and understand their relevance to injury data collection, • Identify the basic principles for various scaling and scoring tools such as the ICD-10-CM, Trauma Score, Revised Trauma Score, Abbreviated Injury Scale, Injury Severity Score, TRISS, etc., • Understand the assignment of injury severity values using the tools listed above, and their importance, • Identify the process of reviewing and abstracting medical records of seriously injured trauma victims, • State the assignment of e-codes and their significance, • Utilize ICD-10-CM coding of complex multiple trauma patients with solid organ injuries in practice, • Identify various methods of data presentation, • Identify the basic principles of Inter-Rater Reliability audits, • Describe the differences between coding for reimbursement versus injury severity, • Identify multidisciplinary members of a trauma quality and process improvement committee and discuss methodology for process and quality improvement, • Achieve familiarity with computer hardware and software commonly used in trauma registers, • Understand the significance of confidentiality concerning patient data and be able to develop safeguards to maintain these standards in the safe use of Trauma Register data and reports, • Verbalize the importance of complete and comprehensive documentation as it relates to injury severity and reimbursement and imbursement.

Simulation Training for Maintenance of Certification in Anesthesiology (MOCA) is organized by Cedars-Sinai Medical Center and will be held on Oct 26, 2020 at Cedars-Sinai Women’s Guild Simulation Center, Los Angeles, California, United States of America. Target Audience: Specialties - Anesthesiology, Other Accreditation: Credit Designation Statement: Cedars-Sinai Medical Center designates this for a maximum of 7.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Credits: AMA PRA Category 1 Credit(s)™ (MD, DO) (7.50 hours), Non-Physician Attendance (RN, NP, PA and Others) (7.50 hours) Overview: The purpose of this simulated activity is to provide anesthesiologists with case scenarios that may be seen in daily practice. They will complete the simulation and reflect individually and as a group on their performances with guided debriefing. The Cedars-Sinai Medical Center Department of Anesthesiology & Peri-operative Care faculty and staff are dedicated to the ABA MOCA components including adherence to good professional standing, lifelong learning and self assessment, cognitive examination, and practice performance assessment and improvement. This course will be offered on four separate dates in 2020: Friday, April 3, 2020 Monday, October 26, 2020 Monday, November 23, 2020 Monday, December 7, 2020 Objectives: • Decrease the instance of vague or disorganized communication, and thereby improve patient safety though the use of communication verification tools and clear multi-departmental communication • Decrease the occurrence of morbidity and mortality through effective timing and utilization of resources in emergency situations • Provide effective management of hemodynamic and respiratory critical events in anesthesia • Provide a broader differential diagnosis during debriefing sessions by recognizing and eliminating potential areas of cognitive bias • Reflect on the teamwork, leadership and communication skills required in crisis management • Develop a process improvement plan to implement at home institution